Eric J Stanbridge

Title: Innovations by Eric J Stanbridge

Introduction

Eric J Stanbridge is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of medical research, particularly in the area of hypoxia-related conditions. With a total of 8 patents, his work focuses on innovative methods to combat diseases through the inhibition of hypoxia-inducible factors.

Latest Patents

One of his latest patents is titled "Inhibition of hypoxia-inducible factor activity with carica papaya extracts." This invention utilizes an extract of leaves from a plant that is six months old or younger to effectively block hypoxia-inducible factor (HIF) function. The method aims to eliminate unwanted cells by inhibiting HIF, which is crucial in the prevention and treatment of various hypoxia-related conditions, including inflammatory diseases, vascular diseases, cancer, and infectious diseases. Another significant patent is the "Hypoxia Inducible Factor (HIF) Activity Reporter Cell Line." This invention involves the construction of a new HIF-responsive reporter gene construct and a stable cell line that can identify modulators of HIF activity.

Career Highlights

Throughout his career, Eric has worked with prestigious institutions such as the University of California and Universiti Putra Malaysia. His research has been instrumental in advancing the understanding of HIF and its implications in various medical conditions.

Collaborations

Eric has collaborated with notable colleagues, including Norazizah Shafee and Khatijah Mohd Yusoff, contributing to the collective knowledge in the field of hypoxia research.

Conclusion

Eric J Stanbridge's innovative work and patents reflect his dedication to advancing medical science and improving treatment options for hypoxia-related diseases. His contributions continue to inspire future research and innovation in this critical area.